Skip to main content
SpringerLink
Log in

Biochip analysis of BRCA1/2 and CHEK2 common mutations in ovarian cancer and primary multiple tumors involving the ovaries (Russian population)

  • Genomics. Transcriptomics. Proteomics
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Ovarian cancer (OC) is among the leading causes of cancer-related mortality in women. A high risk of OC (lifetime estimates ranging 10–60%) is determined by BRCA1/2 mutations. The 1100delC variant of CHEK2 is associated with predisposition to breast cancer (BC) in women. With the known spectrum and frequencies of mutations of these genes, it is possible to identify a risk group in a population. Using biochip technology, the frequencies of eight BRCA1/2 and CHEK2 mutations (185delAG, 300T>G, 4153delA, 4158A>G, and 5382insC of BRCA1; 695insT and 6174delT of BRCA2; and 1100delC of CHEK2) were studied in Russian women with OC, including 68 patients with organ-specific OC and 19 with primary multiple tumors (PMTs) involving the ovaries. Four BRCA1 mutations were observed: 185delAG, 300T>G, 4153delA, and 5382insC. The last one was most common in OC, accounting for 87.5% of all cases with mutant BRCA1, and occurred at a frequency of 50.0% in PMT. BRCA2 and CHEK2 mutations were not found in the two groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cannistra S.A. 2004. Cancer of the ovary. N. Engl. J. Med. 351, 2519–2529.

    Article  PubMed  CAS  Google Scholar 

  2. Memarzadch S., Berek J.S. 2001. Advances in the management of epithelial ovarian cancer. J. Reprod. Med. 46, 621–630.

    Google Scholar 

  3. Sel’chuk V.Yu., Popova T.N., Aver’yanova S.V. 2001. Primary miltiple synchronous malignancies of the female reproductive system. Ross. Onkol. Zh. 3, 18–21.

    Google Scholar 

  4. Van den Berghe H., Dal Cin P. 1998. Some genetic aspects of ovarian tumors. Eur. J. Obstet. Gynecol. Reprod. Biol. 81, 283–287.

    Article  PubMed  Google Scholar 

  5. Narod S.A., Boyd J. 2002. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr. Opin. Obstet. Gynecol. 14, 19–26.

    Article  PubMed  Google Scholar 

  6. Miki Y., Swensen J., Shattuck-Eidens D., et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266, 66–71.

    Article  PubMed  CAS  Google Scholar 

  7. Wooster R., Bignell G., Lancaster J., et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378, 789–792.

    Article  PubMed  CAS  Google Scholar 

  8. Easton D.F., Ford D., Bishop D.T. 1995. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am. J. Hum. Genet. 56, 265–271.

    PubMed  CAS  Google Scholar 

  9. Takahashi H., Chiu H.C., Bandera C.A., et al. 1996. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer. Res. 56, 2738–2741.

    PubMed  CAS  Google Scholar 

  10. Claus E.B., Schildkraut J.M., Thompson W.D., Risch N.J. 1996. The genetic attributable risk of breast and ovarian cancer. Cancer. 77, 2318–2324.

    Article  PubMed  CAS  Google Scholar 

  11. Bell D.W., Varley J.M., Szydlo T.E., et al. 1999. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 286, 2528–2531.

    Article  PubMed  CAS  Google Scholar 

  12. Meijers-Heijboer H., van den Ouweland A., Klijn J., et al. 2002. CHEK2-Breast Cancer Consortium. Lowpenetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genet. 31, 55–59.

    Article  PubMed  CAS  Google Scholar 

  13. Seppala E.H., Ikonen T., Mononen N., et al. 2003. CHEK2 variants associate with hereditary prostate cancer. Br. J. Cancer. 89, 1966–1970.

    Article  PubMed  CAS  Google Scholar 

  14. Antoniou A., Pharoah P.D., Narod S., et al. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130.

    Article  PubMed  CAS  Google Scholar 

  15. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. 2002. Prevention and observation of surgical end points study group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346, 1616–1622.

    Article  PubMed  Google Scholar 

  16. Kauff N.D., Satagopan J.M., Robson M.E., et al. 2002. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 346, 1609–1615.

    Article  PubMed  Google Scholar 

  17. Loginova A.N., Pospekhova N.I., Lyubchenko L.N., Budilov A.V., Zakhar’ev V.M., Gar’kavtseva R.F., Ginter E.K., Karpukhin A.V. 2003. Spectrum of mutations in the BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull. Exp. Biol. Med. 136, 276–278.

    Article  PubMed  CAS  Google Scholar 

  18. Gayther S.A., Harrington P., Russell P., Kharkevich G., Garkavtseva R.F., Ponder B.A. 1997. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60, 1239–1242.

    PubMed  CAS  Google Scholar 

  19. Tillib S.V., Strizhkov B.N., Mirzabekov A.D. 2001. Integration of multiple PCR amplifications and DNA mutation analyses by using oligonucleotide microchip. Anal. Biochem. 292, 155–160.

    Article  PubMed  CAS  Google Scholar 

  20. Gorbunova V.N., Baranov V.S. 1997. Vvedenie v molekulyarnuyu diagnostiku i genoterapiyu nasledstvennykh zabolevanii (Introduction into Molecular Diagnosis and Gene Therapy of Hereditary Diseases). St. Petersburg: Spetsial’naya Literatura.

    Google Scholar 

  21. Fedorova O.E., Sinitska O.N., Tikhomirova L.P., Vishnevskaya Ya.V., Zasedatelev A.S., Nasedkina T.V. 2006. Analysis of point mutations in the BRCA1 gene by hybridization with hydrogel microchips. Mol. Biol. 40, 31–36.

    Article  CAS  Google Scholar 

  22. Glotov A.S., Nasedkina T.V., Ivashchenko T.E., Baranov V.S., Yurasov R.A., Surzhikov S.A., Pan’kov S.V., Chudinov A.V., Baranov V.S., Zasedatelev A.S. 2005. Development of a biochip for analyzing polymorphism of the biotransformation genes. Mol. Biol. 39, 403–412.

    Article  CAS  Google Scholar 

  23. Roa B.B., Boyd A.A., Volcik K., Richards C.S. 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet. 14, 185–187.

    Article  PubMed  CAS  Google Scholar 

  24. Ciernikova S., Tomka M., Kovac M., Stevurkova V., Zajac V. 2006. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma. 53, 97–102.

    PubMed  CAS  Google Scholar 

  25. van der Looij M., Szabo C., Besznyak I., Liszka G., Csokay B., Pulay T., Toth J., Devilee P., King M.C., Olah E. 2000. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int. J. Cancer. 86, 737–740.

    Article  Google Scholar 

  26. Papp J., Raicevic L., Milasin J., Dimitrijevic B., Radulovic S., Olah E. 1999. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families. Oncol. Rep. 6, 1435–1438.

    PubMed  CAS  Google Scholar 

  27. Csokay B., Tihomirova L., Stengrevics A., Sinicka O., Olah E. 1999. Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Hum. Mutat. 14, 92.

    Article  PubMed  CAS  Google Scholar 

  28. Gorski B., Byrski T., Huzarski T., Jakubowska A., Menkiszak J., Gronwald J., Pluzanska A., Bebenek M., Fischer-Maliszewska L., Grzybowska E., Narod S.A., Lubinski J. 2000. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am. J. Hum. Genet. 66, 1963–1968.

    Article  PubMed  CAS  Google Scholar 

  29. Neuhausen S.L. 2000. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2, 77–81.

    Article  PubMed  CAS  Google Scholar 

  30. Oszurek O., Gorski B., Gronwald J., et al. 2001. Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families. Clin. Genet. 60, 470–471.

    Article  PubMed  CAS  Google Scholar 

  31. Hanson K.P., Imyanitov E.N. 2000. Molecular geneticks of ovarian cancer. Prakt. Onkol. 4, 3–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia

    O. E. Fedorova, A. S. Zasedatelev & T. V. Nasedkina

  2. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia

    L. N. Lyubchenko, Yu. G. Payanidi, T. P. Kazubskaya, F. A. Amosenko & R. F. Garkavtseva

  3. Medical Genetic Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia

    F. A. Amosenko

Authors
  1. O. E. Fedorova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. N. Lyubchenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu. G. Payanidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. P. Kazubskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. A. Amosenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. F. Garkavtseva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. S. Zasedatelev
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. V. Nasedkina
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Original Russian Text © O.E. Fedorova, L.N. Lyubchenko, Yu.G. Payanidi, T.P. Kazubskaya, F.A. Amosenko, R.F. Garkavtseva, A.S. Zasedatelev, T.V. Nasedkina, 2007, published in Molekulyarnaya Biologiya, 2007, Vol. 41, No. 1, pp. 37–42.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fedorova, O.E., Lyubchenko, L.N., Payanidi, Y.G. et al. Biochip analysis of BRCA1/2 and CHEK2 common mutations in ovarian cancer and primary multiple tumors involving the ovaries (Russian population). Mol Biol 41, 32–36 (2007). https://doi.org/10.1134/S0026893307010050

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893307010050

Key words

Search

Navigation